Erythromycin: safety issues-Reference-Cited by-同舟云学术

Erythromycin: safety issues

Published:2018 Issue:3 Volume:20 Page:199-204
ISSN:2686-9586
Container-title:Clinical Microbiology and Antimicrobial Chemotherapy
language:ru
Short-container-title:CMAC

Author:

Matveev Alexander V.¹,Krasheninnikov A.E.²,Egorova E.A.³

Affiliation:

1. Medical Academy named after S.I. Georgievsky, Simferopol, Republic of Crimea, Russia National Pharmacovigilance Research Center, Moscow, Russia

2. National Pharmacovigilance Research Center, Moscow, Russia

3. Medical Academy named after S.I. Georgievsky, Simferopol, Republic of Crimea, Russia

Abstract

Macrolide antimicrobials are widely used for the treatment of variety of communityacquired bacterial infections. This paper is aimed to review the data on the safety issues of erythromycin. The main attention is paid to the studies on erythromycin prokinetic properties, cardiotoxicity and fetotoxicity.

Publisher

Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Epidemiology

Reference50 articles.

1. Posohova К.А., Viktorov A.V. Antibiotics. Tepnopol: TGMY, «Ukrmedkniga», 2005. 296 p. Russian.

2. Yakovleva V.P., Yakovleva S.V. Rational antimicrobial pharmacotherapy: a guide for practicing physicians. M.: Litterra, 2003. 1008 p. Russian.

3. Strachunskij L.S., Belousovа Yu.B., Kozlov S.N. Practical guidance on anti-infectious chemotherapy. Smolensk: MAKMAX, 2002. 350 p. Russian.

4. Shilenkova V.V. Five reasons to prescribe macrolides in diseases of ENT organs. Medicinskij sovet. 2016;9:40-44. Russian.

5. Amirov N.B., Vizel A.A. Macrolides in the treatment of various bacterial infections. Vestnik sovremennoj klinicheskoj mediciny. 2012;5(4):43. Russian.